Vulvar squamous cell carcinoma research hub

(APOLLO)Neo-adjuvant Pembrolizumab in vulvar squamous cell carcinoma: a clinical proof-of-concept study

This study is looking at a new way to treat vulvar squamous cell carcinoma before surgery. Researchers are testing a drug called Keytruda to see if it can shrink tumours and how it affects the body's immune cells, hoping for better treatment outcomes.